REVIEW
Bronchoscopic lung volume reduction in advanced pulmonary emphysema: the safety and efficacy of novel methods
More details
Hide details
1
1st Pneumonology Medicine Department, National and Kapodistrian University of Athens, “Sotiria” Chest Diseases Hospital, Athens, Greece
Corresponding author
Grigoris Stratakos
1st Pneumonology Medicine Department, National and
Kapodistrian University of Athens, “Sotiria” General
Hospital,
152 Messogion Ave. Athens, Greece
Pneumon 2012;25(1):35-49
KEYWORDS
ABSTRACT
Large multicentre studies have shown the effectiveness of lung volume reduction surgery (LVRS) in improving functional parameters and exercise tolerance in selected patients with severe pulmonary emphysema of upper lobe predominance. A number of bronchoscopic techniques have been developed under the term bronchoscopic lung volume reduction” (BLVR), which aim to lower the complications and cost of LVRS. These include airway bypass by creation of airway/parenchyma communications under ultrasound (US) guidance, the use of one-way endobronchial valves and endobronchial coils, hot vapour ablation, and “biological” lung volume reduction through alveolar filling with polymer material. These methods are generally simple and safe, with a favourable complications profile, and they require less infrastructure and interventional experience than the open surgical approach. Airway bypass, although effective and relatively safe, does not provide lasting effects. The use of valves and alveolar filling polymers, in contrast, has been shown to produce sustainable improvement of exercise tolerance and quality of life (QoL). Alveolar filling, at the cost of being non-reversible, presents advantages regarding spirometry values, QoL, exercise tolerance and dyspnoea, not only in patients with heterogeneous upper lobe emphysema, but also in patients with homogeneous emphysema, in whom most of the other bronchoscopic or surgical procedures are not indicated. Coils and vapour ablation still need more extensive research to validate their clinical effectiveness. To date, the research data on the effectiveness of BLVR are not yet considered to provide sufficient evidence for official therapeutic recommendations of their use to be launched by the regulating authorities. The cost/effectiveness issue is also under evaluation. New, more extensive multicentre studies are underway which aim at better selection and stratification of patients in order to further evaluate the safety and effectiveness of these techniques, before wider use of this revolutionary approach for severe lung emphysema can be advocated.
REFERENCES (49)
1.
Polkey MI. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171:453-460.
2.
Fessler HE, Scharf SM, Ingenito EP et al. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thor Soc 2008; 5:416-420.
3.
Cooper JD, Patterson GA. Lung volume reduction surgery for severe emphysema. Chest Surg Clin N Am 1995; 5:815-831.
4.
Criner GJ, Cordova FC, Furukawa S, et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:2018-27.
5.
Fishman A, Martinez F, Naunheim K et al. A randomized trial comparing lung volume reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073.
6.
Hopkinson NS, Toma TP, Hansell D, Goldstraw P, Moxham J, Geddes D. A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe Emphysema. National Emphysema Treatment Trial Research Group. N Engl J Med 2003; 348:2059-2073.
7.
National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001; 345:1075-83.
8.
National Emphysema Treatment Trial Research Group. Rational and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg 1999;118:518-28.
9.
Criner GJ, Sternberg AL. National Emphysema Treatment Trial: The major outcomes of lung volume reduction in severe emphysema. Proc Am Thor Soc 2008;5:393-405.
10.
Μπακάκος Π, Κωστίκας Κ, Λουκίδης Σ. ΧΑΠ και συνοσηρότητες. Πνεύμων 2010; 23:21-27.
11.
Λουκίδης Σ, Γάκη Ε. Εγχείρηση μείωσης όγκου του πνεύμονα: Από την πλευρά του Πνευμονολόγου. Πνεύμων 2005; 18:156-162.
12.
Ramsey SD, Sullivan SD, Kaplan RM. Cost-Effectiveness of Lung Volume Reduction Surgery. Proc Am Thorac Soc 2008; 5:406–411.
13.
DeCamp M, McKenna RJ, Deschamps CC, Krasna MJ. Lung Volume Reduction Surgery. Technique, Operative Mortality, and Morbidity. Proc Am Thorac Soc 2008; 5:442–446.
14.
Berger R, DeCamp M, Criner G, Celli B. Lung Volume Reduction Therapies for Advanced Emphysema An Update. Chest 2010; 138:407-417.
15.
Macklem PT. Collateral ventilation. N Engl J Med 1978; 298:49-50.
16.
Lausberg HF, Chino K, Patterson GA, Meyers BF, Toeniskoetter PD, Cooper JD. Bronchial Fenestration improves expiratory flow in emphysematous human lungs. Ann Thor Surg 2003; 75:393-398.
17.
Rendina EA, De Giacomo T, Venuta F, Furio Coloni G, Meyers BF, Patterson A. Feasibility and safety of the airway bypass procedure for patients with emphysema. J Thorac Cardiovasc Surg 2003; 125:1294-1299.
18.
Choong CK, Haddad FJ, Gee EY, Cooper JD. Feasibility and safety of airway bypass stent placement and influence of topical mitomycin C on stent patency. J Thorac Cardiovasc Surg 2005; 129:632-638.
19.
Cardoso PFG, Snell GI, Hopkins P et al. Clinical application of airway bypass with paclitaxel-eluting stents: Early results. J Thorac Cardiovasc Surg 2007; 134:974-981.
20.
Sybrecht GW, Shah P, Slebos DJ et al. Clinical Trial «EASE - randomized trial of airway bypass in homogeneous emphysema» Oral Presentation 5697 Tuesday, September 21, ERS 2010.
21.
Sabanathan S, Richardson J, Pieri-Davies S. Bronchoscopic lung volume reduction. The Journal of cardiovascular surgery 2003; 44:101-108.
22.
Wood D, McKenna R, Jusen RD, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007; 133:65-73.
23.
Coxson HO, Nasute Fauerbach PV, Storness-Bliss C, Muller NL. Computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J 2008; 32:1443–1450.
24.
Sterman DH, Mehta AC, Wood DE et al; for the IBV Valve Pilot Trial Research Team. A multicenter Pilot Study of a Bronchial Valve for the Treatment of Severe Emphysema. Respiration 2010; 79:222-233.
26.
Venuta F, Rendina E, De Giacomo T, Coloni G. Bronchoscopic lung volume reduction. Multimedia Manual of Cardiothoracic Surgery doi 10.1510/mmcts.2006.002121.
27.
Snell G, Holsworth L, Borrill Z et al. The Potential for Bronchoscopic Lung Volume Reduction Using Bronchial Prostheses. Chest, 2003; 124:1073-1080.
28.
Ingenito EP, Wood D, Utz J. Bronchoscopic Lung volume reduction in severe emphysema. Proc Am Thor Soc 2008; 5:454-460.
29.
Wan IY, Toma TP, Geddes DM et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006; 129:518-526.
30.
Sciurba F, Ernst A, Herth F, Strange C, Criner G, Marquette C, Vent Study Research Group. A randomized Study of Endobronchial Valves for Advanced Emphysema. N Engl J Med 2010; 363:1233-1244.
31.
Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJF. Predicting Atelectasis by Assessment of Collateral Ventilation prior to Endobronchial Lung Volume Reduction: A Feasibility Study. Respiration DOI:10.1159/000319441, Published Online: July 21, 2010.
32.
Ernst A, Eberhardt R, Gompelmann D, Herth FJ. Low degree of collateral ventilation measurement in heterogeneous emphysema subject treated by endobronchial lung volume reduction predicts ELVR success. Thematic Poster, ATS 2010. Am J Respir Crit Care Med 2010; 181:A1571.
33.
Ernst A, Eberhardt R, Gompelmann D, Herth FJ. High Degree Of Collateral Ventilation Measurement In Heterogeneous Emphysema Subject Treated By Endobronchial Lung Volume Reduction Predicts ELVR Failure. Thematic Poster, ATS 2010. Am J Respir Crit Care Med 2010; 181:A1572.
34.
Ost D, Ernst A, Maxfield R, et al. Evaluation of a bronchoscopically delivered non-valve implant that mechanically compresses diseased lung for the treatment of emphysema. Paper presented at: European Respiratory Society Annual Congress; October 4-8, 2008; Berlin, Germany; abstract 1588.
35.
ΜcKenna R, Ernst A, Maxfield R, et al. Novel implant device and procedure to compress lung parenchyma for the treatment of emphysema via bronchoscope. Paper presented at: European Respiratory Society Annual Congress; October 4-8, 2008; Berlin, Germany; abstract 2825.
36.
Herth F, Eberhardt R, Ernst A. Non-valve minimally invasive implantable device for the treatment of late stage homogeneous and heterogeneous emphysema: results of a feasibility trial. Paper presented at: European Respiratory Society Annual Congress; October 4-8, 2008; Berlin, Germany; abstract 1589.
37.
Slebos DJ, Kerstjens HAM, Ernst A, Blaas SH, Gesierich WJ, Herth F. Bronchoscopic lung volume reduction coil treatment of severe heterogeneous emphysema. Oral Presentation: Inverventions for obstructive lung diseases [3418] ERS 2010.
38.
Kemp S, Shah P, Slebos DJ, Ernst A, Herth F. Relationships between baseline quantitative CT densitometry and change in outcome measures following lung volume reduction coil (LVRC) treatment Oral Presentation: Inverventions for obstructive lung diseases [P4143] ERS 2010.
39.
Herth F, Eberhard R, Gompelmann D, et al. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study Ther Adv Respir Dis 2010; 4:225-231.
40.
Emery Μ, Eveland R, Eveland K, Couetil L, Hildebrandt J, Swenson E. Lung Volume Reduction by Bronchoscopic Administration of Steam. Am J Respir Crit Care Med 2010; doi:10.1164/ rccm.201001-0102OC.
41.
Snell GI, Hopkins P, Westall G et al. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg 2009; 88:1993–1998.
42.
Eberhardt R, Schmidt B, Ernst A, Ficker J, Snell GI, Herth FJ. Germany Pilot Safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance. ATS Presentation Wednesday, November 4, 2009.
43.
Herth F, Eberhardt E, Ernst A et al. The Efficacy Of Bronchoscopic Thermal Vapor Ablation (BTVA) In Patients With Upper Lobe Emphysema: The impact of heterοgeneity of disease. Am J Respir Crit Care Med 2010; 181:A5167; ATS2010.
44.
Ingenito E, Berger R, Cortney Henderson A, Reilly J, Tsai L, Hoffman A. Bronchoscopic Lung Volume Reduction Using Tissue Engineering Principles. Am J Respir Crit Care Med Vol 2003; 167:771–778.
45.
Criner G, Pinto-Plata V, Strange C, et al. Biologic Lung Volume Reduction (BioLVR) In Advanced Upper Lobe Emphysema: Phase 2 Results. Am J Respir Crit Care Med January 29, 2009 doi:10.1164/rccm.200810-1639OC.
46.
Refaely Y, Dransfield M, Kramer MR et al. Biologic Lung Volume Reduction therapy for Advanced homogeneous emphysema. European Respiratory Journal 2010, 36: 20-27.
47.
Herth FJF, Gompelmann D, Bonnet R et al. Treatment of Advanced Emphysema with Emphysematous Lung Sealant (Aeriseal) Respiration 2010 DOI: 10.1159/000322649.
48.
Presentation on Aeriseal at: XII International Meeting on respiratory endoscopy, 5-7 May 2011, Sitges, Spain.